Outset Medical, Inc. 8-K

What Happened
Outset Medical, Inc. (OM) filed an 8‑K (Item 5.02) on May 29, 2026 reporting that Marc Nash, Executive Vice President, R&D, Operations and Service, informed the company on May 26, 2026 that he will depart effective June 5, 2026 to pursue other professional opportunities. The company states Mr. Nash’s departure is not due to any dispute or disagreement with the company or its management. The report was signed by John Brottem, General Counsel.

Key Details

• Employee: Marc Nash, Executive Vice President, R&D, Operations and Service.
• Notice given: May 26, 2026; Effective date: June 5, 2026.
• Filing: Form 8‑K dated May 29, 2026 under Item 5.02 (departure of certain officers).
• The filing states the departure is not due to any dispute or disagreement and does not disclose a successor, transition plan, or severance details.

Why It Matters
This is a material executive change in the company’s R&D and operations leadership. For investors, the facts to watch are any announcements about an interim or permanent replacement and any related operational or integration impacts. The 8‑K indicates a voluntary departure with no dispute; the company’s future filings or press releases should be monitored for succession details and any potential effects on product development or operations.